Multiple Myeloma, Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, "Not-So-Benign" Hematology, Myelodysplastic Syndromes, Myeloproliferative Neoplasms, Lymphoproliferative Diseases
Conference Chairs: John. P Leonard, MD, Weill Cornell Medicine; Joseph Mikhael, MD, City of Hope Cancer Center; David P. Steensma, MD, Dana-Farber Cancer Institute
This event offers
12.25 CME credits
CE accredited by NACCME and Imedex.
Interested In Attending This Event?
Additional Registration Information:
Save $50 on registration costs with code: "GDUHEM50"
Join us for a unique educational experience. In this 2-day, debate-style series, nationally recognized thought leaders take opposing sides on clinical—and sometimes controversial—topics currently disrupting the practice of hematology and oncology.
Through comprehensive review of the latest clinical advancements in hematologic malignancies, robust audience engagement, and ample discussion, participants will leave equipped with practical implications and applications to put into practice immediately.
This live educational activity is designed to meet the educational needs of those who are involved and/or interested in the treatment of patients with multiple myeloma, lymphoma, chronic lymphocytic leukemia, and acute myeloid leukemia.